The invention discloses a
drug for treating hemophilia. The
drug is prepared from 15-25 parts by weight of buffalo horn, 15-25 parts by weight of unprocessed
rehmannia root, 5-15 parts by weight of lalang grass
rhizome, 5-15 parts by weight of stir-baked
Gardenia jasminoides, 15-25 parts by weight of root
bark of the peony tree, 10-20 parts by weight of red peony root, 10-20 parts by weight of radix scrophulariae, 10-15 parts by weight of nodus nelumbinis rhizomatis
charcoal, 10-20 parts by weight of madder, 20-30 parts by weight of
rheum officinale charcoal, 10-20 parts by weight of
achyranthes root, 15-20 parts by weight of pseudo-
ginseng, 5-10 parts by weight of Circium japonicum, 5-10 parts by weight of common cephalanoplos
herb, 10-15 parts by weight of radix astragali, 10-20 parts by weight of
donkey-hide
gelatin, 15-20 parts by weight of pilose asiabell root, 15-25 parts by weight of licorice root, 10-20 parts by weight of
pseudostellaria root, 20-30 parts by weight of
Codonopsis pilosula Nannf., 10-20 parts by weight of radix angelicae sinensis, 20-25 parts by weight of
radix aconiti lateralis praeparata slice, 10-20 parts by weight of fleece-flower root, 10-20 parts by weight of dark plum, 10-20 parts by weight of
spatholobus stem, 15-20 parts by weight of
ligusticum wallichii, 10-20 parts by weight of radix arnebiae seu lithospermi, 10-15 parts by weight of Radix et Rhizoma Rhei, 10-20 parts by weight of tortoiseshell and 5-10 parts by weight of carapax trionycis. Through dialectical compatibility, the
drug has effects of dredging stasis and nourishing blood, nourishing yin and clearing heat, cooling blood and stopping bleeding, tonifying Qi and diminishing
inflammation, has substantial hemophilia curative effects and has no toxic or side effects.